Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Liabilities from Discontinued Operations (2024 - 2025)

Historic Liabilities from Discontinued Operations for Sanofi (SNY) over the last 3 years, with Q2 2025 value amounting to $2.3 million.

  • Sanofi's Liabilities from Discontinued Operations changed N/A to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $2.3 billion for FY2024, which is N/A changed from last year.
  • Sanofi's Liabilities from Discontinued Operations amounted to $2.3 million in Q2 2025.
  • Sanofi's 5-year Liabilities from Discontinued Operations high stood at $2.3 billion for Q4 2024, and its period low was $2.3 million during Q2 2025.